TY - JOUR
T1 - Feasibility of non-enhanced CT for assessing longitudinal changes in hepatic steatosis
AU - Kim, Min Gi
AU - Lee, Seung Soo
AU - Jun, Myung Joon
AU - Byun, Jieun
AU - Sung, Yu Sub
AU - Shin, Youngbin
AU - Lee, Moon Gyu
N1 - Publisher Copyright:
Copyright © 2019 the Author(s).
PY - 2019/5/1
Y1 - 2019/5/1
N2 - To evaluate the feasibility of computed tomography (CT) in the assessment of the change in hepatic steatosis (HS) in longitudinal follow-up by employing pathological HS as the reference standard. We retrospectively evaluated 38 living liver donor candidates (27 men and 11 women; mean age, 29.5 years) who underwent liver biopsy twice and had liver CT scans within 1 week of each biopsy. Four readers independently calculated CTL-S index by subtracting spleen attenuation from liver attenuation on non-enhanced CT images. The changes in pathological HS (DHS) and CTL-S (DCTL-S) between the 1st and 2nd examinations were assessed. The correlation between DHS and DCTL-S was assessed using the linear regression analysis. Inter-observer measurement error for DCTL-S among the 4 readers was assessed using the repeatability coefficient. DCTL-S showed a significant correlation with DHS in all readers (r = 0.571–0.65, P < .001). The inter-observer measurement error for DCTL-S was ±8.9. The DCTL-S values beyond the measurement error were associated with a consistent change in HS in 83.3% (13/15) to 100% (15/15), with sensitivities of 47.8 to 79.9% and specificities of 86.7 to 100% for detecting an absolute change of ≥10% in HS among the 4 readers. However, DCTL-S values within the measurement error were associated with a consistent change in HS in 43.5% (8/19) to 61.5% (16/26). The change in CTL-S roughly reflects the change in HS during longitudinal follow-up. A small change in CTL-S should not be considered meaningful, while a larger change in CTL-S beyond the measurement error strongly indicates a true change in HS. Abbreviations: ALT = alanine aminotransferase, AST = aspartate aminotransferase, BMI = body mass index, CT = computed tomography, HS = hepatic steatosis, HSI = hepatic steatosis index, HU = Hounsfield unit, ICC = intraclass correlation coefficient, MR = magnetic resonance, ROI = region-of-interest, US = ultrasonography.
AB - To evaluate the feasibility of computed tomography (CT) in the assessment of the change in hepatic steatosis (HS) in longitudinal follow-up by employing pathological HS as the reference standard. We retrospectively evaluated 38 living liver donor candidates (27 men and 11 women; mean age, 29.5 years) who underwent liver biopsy twice and had liver CT scans within 1 week of each biopsy. Four readers independently calculated CTL-S index by subtracting spleen attenuation from liver attenuation on non-enhanced CT images. The changes in pathological HS (DHS) and CTL-S (DCTL-S) between the 1st and 2nd examinations were assessed. The correlation between DHS and DCTL-S was assessed using the linear regression analysis. Inter-observer measurement error for DCTL-S among the 4 readers was assessed using the repeatability coefficient. DCTL-S showed a significant correlation with DHS in all readers (r = 0.571–0.65, P < .001). The inter-observer measurement error for DCTL-S was ±8.9. The DCTL-S values beyond the measurement error were associated with a consistent change in HS in 83.3% (13/15) to 100% (15/15), with sensitivities of 47.8 to 79.9% and specificities of 86.7 to 100% for detecting an absolute change of ≥10% in HS among the 4 readers. However, DCTL-S values within the measurement error were associated with a consistent change in HS in 43.5% (8/19) to 61.5% (16/26). The change in CTL-S roughly reflects the change in HS during longitudinal follow-up. A small change in CTL-S should not be considered meaningful, while a larger change in CTL-S beyond the measurement error strongly indicates a true change in HS. Abbreviations: ALT = alanine aminotransferase, AST = aspartate aminotransferase, BMI = body mass index, CT = computed tomography, HS = hepatic steatosis, HSI = hepatic steatosis index, HU = Hounsfield unit, ICC = intraclass correlation coefficient, MR = magnetic resonance, ROI = region-of-interest, US = ultrasonography.
KW - computed tomography
KW - hepatic steatosis
KW - liver
UR - http://www.scopus.com/inward/record.url?scp=85066061210&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000015606
DO - 10.1097/MD.0000000000015606
M3 - Article
C2 - 31083253
AN - SCOPUS:85066061210
SN - 0025-7974
VL - 98
JO - Medicine (United States)
JF - Medicine (United States)
IS - 19
M1 - e15606
ER -